Pluristem Therapeutics Announces First Patient Enrollment In Phase I Clinical Trial For Treatment Of Peripheral Artery Disease With PLX-PAD
Links shared publicly online about this topic.
- 1,915total visits
Pluristem Therapeutics Announces First Patient Enrollment In Phase I Clinical Trial For Treatment Of Peripheral Artery Disease With PLX-PAD
Pluristem therapeutics inc. (nasdaqcm:psti) (dax:pjt), a bio-therapeutics company dedicated to the commercialization of unrelated donor-patient (allogeneic) cell therapy products for a variety of
View full resource at medicalnewstoday.com
Tags: Circulation, Circulatory Disorders, Peripheral Artery Disease, Thrombotic Event, Disease and Condition, Clinical Trial
Most Recently Shared on July 7, 2009 at 4:29 pm By:
MedicalNewsToday: Pluristem Therapeutics Announces First Patient Enrollment In: http://tinyurl.com/lzkkyz Full http://tinyurl.com/l4pdbn
Advertisement
